Cargando…
Development of sweet potato (Ipomoea batatas Lamk.) as excipient in tablet formulation
Background: Sweet potato has a potential to be used as a raw material for tablets. However, it needs chemical modifications to produce derivatives with excellent pharmaceutical characteristics. The primary purpose of this research was to use sweet potato starch (Ipomoea batatas Lamk.) as a tablet ex...
Autores principales: | Mahalia, Lamia Diang, Supriyanto, Stefanus, Syukri, Yandi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376492/ https://www.ncbi.nlm.nih.gov/pubmed/32728572 http://dx.doi.org/10.4081/jphr.2020.1831 |
Ejemplares similares
-
Disentangling the Origins of Cultivated Sweet Potato (Ipomoea batatas (L.) Lam.)
por: Roullier, Caroline, et al.
Publicado: (2013) -
Susceptibility of sweet potato (Ipomoea batatas) peel proteins to digestive enzymes
por: Maloney, Katherine P, et al.
Publicado: (2014) -
Biological activities of sweet potato (Ipomoea batatas L.) tips and tubers
por: Hong, Chae Young, et al.
Publicado: (2022) -
Characterization and development of EST-SSR markers in sweet potato (Ipomoea batatas (L.) Lam)
por: Kim, Jin-Hee, et al.
Publicado: (2016) -
IbMADS1 (Ipomoea batatas MADS-box 1 gene) is Involved in Tuberous Root Initiation in Sweet Potato (Ipomoea batatas)
por: Ku, Amy Tsu, et al.
Publicado: (2008)